A newly published peer-reviewed study is bringing renewed attention to how the myocarditis and pericarditis safety signal surrounding mRNA COVID-19 vaccines was identified and communicated in 2021. The study examines the timeline of when the safety concerns were communicated to health authorities and the public. The question isn’t simply whether a potential safety signal exists, but how quickly it’s identified, investigated, communicated, and acted upon.